Aliza Leiser

1.8k total citations · 1 hit paper
29 papers, 1.2k citations indexed

About

Aliza Leiser is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research. According to data from OpenAlex, Aliza Leiser has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 10 papers in Obstetrics and Gynecology and 9 papers in Cancer Research. Recurrent topics in Aliza Leiser's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Cancer survivorship and care (4 papers). Aliza Leiser is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Cancer survivorship and care (4 papers). Aliza Leiser collaborates with scholars based in United States, Australia and United Kingdom. Aliza Leiser's co-authors include Gil Mor, Thomas Rutherford, Ayesha B. Alvero, Peter E. Schwartz, Irene Visintin, Michael Kelly, S. Dennis, Stefan Fest, Ryan Chen and Dan‐Arin Silasi and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Aliza Leiser

27 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

2021 196 citations Matteo Palmeri, Janice M. Mehnert et al. ESMO Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aliza Leiser United States	13	433	404	335	301	228	29	1.2k
Sabrina Chiara Cecere Italy	20	428 1.0×	290 0.7×	615 1.8×	525 1.7×	200 0.9×	71	1.4k
Maria Ornella Nicoletto Italy	18	496 1.1×	324 0.8×	581 1.7×	445 1.5×	187 0.8×	54	1.3k
Marilena Di Napoli Italy	16	331 0.8×	187 0.5×	433 1.3×	374 1.2×	169 0.7×	64	1.0k
Carolyn K. McCourt United States	21	361 0.8×	193 0.5×	429 1.3×	273 0.9×	211 0.9×	84	1.4k
Alicia Beeghly‐Fadiel United States	24	433 1.0×	430 1.1×	529 1.6×	176 0.6×	113 0.5×	74	1.3k
Lingya Pan China	22	494 1.1×	236 0.6×	228 0.7×	590 2.0×	134 0.6×	108	1.4k
Stephen Welch Canada	24	626 1.4×	279 0.7×	1.0k 3.1×	368 1.2×	388 1.7×	124	1.9k
Tomoka Ishibashi Japan	18	447 1.0×	214 0.5×	282 0.8×	410 1.4×	140 0.6×	80	1.1k
Rachel W. Miller United States	15	208 0.5×	237 0.6×	238 0.7×	515 1.7×	112 0.5×	54	959
Chad M. Michener United States	24	411 0.9×	225 0.6×	382 1.1×	562 1.9×	140 0.6×	98	1.6k

Countries citing papers authored by Aliza Leiser

Since Specialization

Citations

This map shows the geographic impact of Aliza Leiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aliza Leiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aliza Leiser more than expected).

Fields of papers citing papers by Aliza Leiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aliza Leiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aliza Leiser. The network helps show where Aliza Leiser may publish in the future.

Co-authorship network of co-authors of Aliza Leiser

This figure shows the co-authorship network connecting the top 25 collaborators of Aliza Leiser. A scholar is included among the top collaborators of Aliza Leiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aliza Leiser. Aliza Leiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leiser, Aliza, et al.. (2024). Severe Epinephrine-Induced Lactic Acidosis. A3414–A3414. 1 indexed citations

Vikas, Praveen, Hans Messersmith, Carolyn C. Compton, et al.. (2023). Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline. Journal of Clinical Oncology. 41(10). 1943–1948. 57 indexed citations

Girda, Eugenia, June Y. Hou, David L. Nelson, et al.. (2022). Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer. International Journal of Gynecological Cancer. 32(8). 1032–1038. 8 indexed citations

Kendig, Tiffany, et al.. (2022). Community-based outpatient cancer rehabilitation services for women with gynecologic cancer: acceptability and impact on patient-reported outcomes. Supportive Care in Cancer. 30(10). 8089–8099. 4 indexed citations

Hui, David, Kari Bohlke, Ting Bao, et al.. (2021). Management of Dyspnea in Advanced Cancer: ASCO Guideline. Journal of Clinical Oncology. 39(12). 1389–1411. 92 indexed citations

Palmeri, Matteo, Janice M. Mehnert, Ann W. Silk, et al.. (2021). Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 7(1). 100336–100336. 196 indexed citations breakdown →

Girda, Eugenia, et al.. (2019). Evaluating unplanned readmission and prolonged length of stay following minimally invasive surgery for endometrial cancer. Gynecologic Oncology. 156(1). 162–168. 11 indexed citations

Orfanelli, Theofano, et al.. (2017). Ogilvie's Syndrome after Robotic-Assisted Radical Hysterectomy for Cervical Cancer. Journal of Minimally Invasive Gynecology. 25(1). 175–179. 2 indexed citations

Rodríguez-Rodríguez, Lorna, Kim M. Hirshfield, Verónica Rojas, et al.. (2016). Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers. Gynecologic Oncology. 141(1). 2–9. 25 indexed citations

10.

Seto‐Young, Donna, Dimiter Avtanski, Miroslava Varadinova, et al.. (2011). Differential Roles of MAPK-Erk1/2 and MAPK-p38 in Insulin or Insulin-Like Growth Factor-I (IGF-I) Signaling Pathways for Progesterone Production in Human Ovarian Cells. Hormone and Metabolic Research. 43(6). 386–390. 11 indexed citations

11.

Visintin, Irene, Ziding Feng, Gary Longton, et al.. (2008). Diagnostic Markers for Early Detection of Ovarian Cancer. Clinical Cancer Research. 14(4). 1065–1072. 307 indexed citations

12.

Chen, Ryan, Ayesha B. Alvero, Dan‐Arin Silasi, et al.. (2008). Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells. Oncogene. 27(34). 4712–4723. 255 indexed citations

13.

Thomas, Mathew, Jason D. Wright, Aliza Leiser, et al.. (2008). Clear cell carcinoma of the cervix: A multi-institutional review in the post-DES era. Gynecologic Oncology. 109(3). 335–339. 53 indexed citations

14.

Leiser, Aliza, Fernando Cotait Maluf, D. S., et al.. (2007). A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer. International Journal of Gynecological Cancer. 17(2). 379–386. 13 indexed citations

15.

Leiser, Aliza, S. Dennis, Nicole Ishill, & William P. Tew. (2007). Carcinosarcoma of the ovary treated with platinum and taxane: The memorial Sloan-Kettering Cancer Center experience. Gynecologic Oncology. 105(3). 657–661. 51 indexed citations

16.

Maluf, Fernando Cotait, Aliza Leiser, Carol Aghajanian, et al.. (2006). Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. International Journal of Gynecological Cancer. 16(3). 1165–1171. 27 indexed citations

17.

Maluf, Fernando Cotait, Aliza Leiser, Paul Sabbatini, et al.. (2006). Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. International Journal of Gynecological Cancer. 16(3). 1165–1171. 8 indexed citations

18.

Leiser, Aliza & Carol Aghajanian. (2006). Evaluation and management of gestational trophoblastic disease. Community Oncology. 3(3). 152–156. 3 indexed citations

19.

Leiser, Aliza, Sibyl Anderson, Daisuke Nonaka, et al.. (2005). Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecologic Oncology. 101(1). 86–91. 44 indexed citations

20.

Leiser, Aliza, et al.. (2004). Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor. Gynecologic Oncology. 94(2). 567–571. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact